Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2014 Jul 30;18(7):1490. doi: 10.1111/jcmm.12323

Corrigendum

PMCID: PMC4124032

In [1], the author affiliations, and corresponding author information were incorrect in some parts. Please find the correct author affiliations and corresponding author information below.

Author affiliations:

Shudong Zhua, b, *, Matthew B. Cohenb, Jeffrey D. Bjorgec, James W. Mierb, Daniel C. Chob, *

aSchool of Life Sciences, State Key Laboratory of Medical Genetics, Central South University, Changsha, China

bDivision of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

cDepartment of Biochemistry and Molecular Biology, Southern Alberta Cancer Research Institute, Calgary, Canada

Corresponding author information:

*Correspondence to: Shudong ZHU, Ph.D., School of Life Sciences, Central South University, 172 TongZiPo Rd, Changsha, China.

Tel.: 731-8265-0460

Fax: 731-8265-0460

E-mail: shudongzhu@csu.edu.cn

The authors wish to apologize for any misunderstanding or inconvenience caused.

References

  • 1.Zhu S, Cohen MB, Bjorge JD, et al. PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells. J Cell Mol Med. 17(3):377–85. doi: 10.1111/jcmm.12019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES